Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 8, Number 11—November 2002

Rifampin- and Multidrug-Resistant Tuberculosis in Russian Civilians and Prison Inmates: Dominance of the Beijing Strain Family

Francis Drobniewski*Comments to Author , Yanina Balabanova*, Michael Ruddy*, Laura Weldon*, Katya Jeltkova†, Timothy Brown*, Nadezdna Malomanova‡, Elvira Elizarova‡, Alexander Melentyey§, Ebgeny Mutovkin§, Svetlana Zhakharova‡, and Ivan Fedorin‡
Author affiliations: *Guy's King's and St Thomas' Medical School, King's College Hospital, London, United Kingdom; †Central Tuberculosis Research Institute, Moscow, Russian Federation; ‡Samara Oblast Dispensary, Samara City, Russian Federation; §Samara Prison TB Service, Samara City, Russian Federation;

Main Article

Table 1

Molecular resistance to rifampin and isoniazid in Mycobacterium tuberculosis isolates with proportional analysis by center/laboratory, Samara Oblast, Russian Federation

Laboratory location No. of isolates examined for rifampin resistance (n=130)a No. of rifampin-resistant isolates (%) No. of isoniazid-resistant isolates (%)b
All 134 78 (58.2) 66 (–)
Prison TB colony 45 36 (80.0) 27 (60.0)
City dispensary 1 11 4 (36.4) 4 (36.4)
City hospital 1 34 18 (52.9) 14 (41.2)
Novokubshev town laboratory 21 9 (42.9) 11 (52.4)
Oblast regional TB laboratory 19 11 (57.9) 10 (52.6)

aOf 140 cultures, 134 results were produced, but only 130 were available for results by center; 2 were M. gordonae, amplification failed for 4 cultures, and center could not be definitively identified for 4.
bOf 140 cultures, amplification products that could be evaluated were obtained from 128 cultures.

Main Article

Page created: July 19, 2010
Page updated: July 19, 2010
Page reviewed: July 19, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.